Selected inclusion criteria | Selected exclusion criteria |
---|---|
1. Histologically and/or cytologically confirmed MPM | 1. Disease suitable for curative surgery |
2. Unresectable disease, not candidate for curative surgery | 2. Previous treatment with a PD1 or PD-L1 inhibitor |
3. Measurable disease, defined as at least one lesion (CT or MRI) that is suitable for repeated assessment | 3. Non-pleural mesothelioma e.g. mesothelioma arising in other organs |
4. Available unstained archived tumour tissue sample | 4. Active second malignancy other than non-melanoma skin cancer or cervical carcinoma in situ |
5. Previously treated with at least one line of platinum doublet | 5. Symptomatic or uncontrolled brain metastases requiring concurrent treatment |
6. ECOG performance status of 0–1 | 6. Known history of leptomeningeal carcinomatosis |
7. Willing to provide archived tumour tissue and blood samples for research | 7. Active or prior documented autoimmune or inflammatory disorders |
8. Adequate organ function | 8. History of primary immunodeficiency |
9. Age ≥ 18 years | 9. History of allogeneic organ transplant |
10. Uncontrolled intercurrent illness | |
11. Active infection |